More than a third of diabetics breaches their insulin treatment
A survey reveals that these patients recognize a dose of therapy up to three times a month.
More than a third of people with diabetes breaches the treatment with insulin prescribed by their doctor or, at least, some dose is skipped, according to the results of the global attitudes survey of patients and doctors with insulin therapy (GAPP), carried out by Novo Nordisk, presented at the Congress of the European Association for the Study of Diabetes (EASD), which is celebrated these days in Stockholm, Sweden.
Patients who do not comply with their treatment also recognize that these forgetfulness usually occur at least three times a month, although professionals believe that the figure could reach six monthly doses.
The study participated about 3,000 people from eight countries, including Spain, and the results also demonstrate that 88% of doctors believe that there is a very significant number of patients who do not reach optimal blood glucose figures.
In fact, they ensure that 40% of diabetes patients have "serious difficulties" to control their blood glucose levels, in line figures with the results obtained in previous research, which already demonstrated that only half of those affected byThis disease has an optimal state of health and life.
Difficult treatment to follow
According to the director associated at the Diabetes Research Institute of the University of Miami, United States, Luigi Meneghini, "it seems that today's lifestyle and the difficulty in adequately fulfilling treatment are determining factors in low controlof the glycemic level ".
In fact, both patients and doctors recognize that changes in daily routine, stress or a simple oblivion are the main reasons that explain this high degree of therapeutic breach.In this sense, more than half of the specialists agree that their patients have difficulties in the management of injections due to the strict treatments.
On the other hand, the survey has also shown that nine out of ten patients (90%) would like to have an insulin that could be administered less frequently than the current one, which is used once a day.
In addition, 67% of them believe that the disease controls their lives since they started treatment.As for specialists, research indicates that a third of them is unsatisfied with the possibility of adapting patient lifestyle treatments.
